Deerfield Management Company, L.p. (series C) Buys Singular Genomics Systems Inc, CareMax Inc, AdaptHealth Corp, Sells Boston Scientific Corp, , Biogen Inc

• New Purchases: OMIC, CMAX, QDEL, GLPG, HOWL, APR, KURA, TERN, GRAY, GRPH, CGEM, AVAH, BHG, SPRB, OM, DAWN, STXS, JANX, QSI, AVTE, PRVA, CNVY, AGL, GHRS, LFST, CVRX, BCAB, EUCRU, RPHM, GLUE, TMPMU, IGNYU, INSM, CHFW.U, BMEA, ACHL, MTCR,
• Added Positions: AHCO, ORGO, LUNG, SILK, DCPH, KALV, VTRS, KNTE, PMVP, VIVO, ARDX, WVE, IMCR, LRMR, BPMC, AERI, NUVB, COGT, PTGX, RVMD, INZY, BCRX, ATEC, RNA, FOLD, DYN, ADVM,
• Reduced Positions: CNC, DFPH, CYTK, BKD, OMI, RETA, LUMO, ZBH, BVS, CNST, PCRX,
• Sold Out: BSX, ALXN, BIIB, DFHT, OCDX, HRC, SHC, CERT, PACB, RUBY, SYK, AUTL, SGFY, STIM, WOOF, INNV, FDMT, GRCL, SNSE, LABP, IMRA,

For the details of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s stock buys and sells, go to https://www.gurufocus.com/guru/deerfield+management+company%2C+l.p.+%28series+c%29/current-portfolio/portfolio

1. Viatris Inc (VTRS) - 18,824,000 shares, 6.69% of the total portfolio. Shares added by 9.29%
2. Singular Genomics Systems Inc (OMIC) - 9,112,019 shares, 6.23% of the total portfolio. New Position
3. CareMax Inc (CMAX) - 16,778,750 shares, 5.38% of the total portfolio. New Position
4. AdaptHealth Corp (AHCO) - 7,353,792 shares, 5.01% of the total portfolio. Shares added by 222.84%
5. Organogenesis Holdings Inc (ORGO) - 7,222,127 shares, 2.99% of the total portfolio. Shares added by 141.09%

Deerfield Management Company, L.p. (series C) initiated holding in Singular Genomics Systems Inc. The purchase prices were between $23.16 and $31.17, with an estimated average price of $25.88. The stock is now traded at around $16.810000. The impact to a portfolio due to this purchase was 6.23%. The holding were 9,112,019 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) initiated holding in CareMax Inc. The purchase prices were between $12.29 and $15, with an estimated average price of $13.45. The stock is now traded at around $7.550000. The impact to a portfolio due to this purchase was 5.38%. The holding were 16,778,750 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) initiated holding in Quidel Corp. The purchase prices were between $104.07 and $132.21, with an estimated average price of $118.06. The stock is now traded at around $121.800000. The impact to a portfolio due to this purchase was 1.3%. The holding were 409,219 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) initiated holding in Galapagos NV. The purchase prices were between $68.86 and $83.34, with an estimated average price of $76.32. The stock is now traded at around $57.140000. The impact to a portfolio due to this purchase was 1.13%. The holding were 657,005 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) initiated holding in Werewolf Therapeutics Inc. The purchase prices were between $11.6 and $17.44, with an estimated average price of $13.73. The stock is now traded at around $17.130000. The impact to a portfolio due to this purchase was 1.11%. The holding were 2,552,787 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) initiated holding in Apria Inc. The purchase prices were between $26.38 and $33.01, with an estimated average price of $29.35. The stock is now traded at around $36.300000. The impact to a portfolio due to this purchase was 1.1%. The holding were 1,572,892 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) added to a holding in AdaptHealth Corp by 222.84%. The purchase prices were between $23.48 and $38.5, with an estimated average price of $28.74. The stock is now traded at around $23.630000. The impact to a portfolio due to this purchase was 3.46%. The holding were 7,353,792 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) added to a holding in Organogenesis Holdings Inc by 141.09%. The purchase prices were between $14.92 and $23.23, with an estimated average price of $18.64. The stock is now traded at around $15.430000. The impact to a portfolio due to this purchase was 1.75%. The holding were 7,222,127 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) added to a holding in Pulmonx Corp by 92.19%. The purchase prices were between $37.61 and $48, with an estimated average price of $43.64. The stock is now traded at around $38.850000. The impact to a portfolio due to this purchase was 0.95%. The holding were 1,800,887 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) added to a holding in Silk Road Medical Inc by 133.04%. The purchase prices were between $44.66 and $63.06, with an estimated average price of $50.91. The stock is now traded at around $53.490000. The impact to a portfolio due to this purchase was 0.78%. The holding were 1,138,525 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) added to a holding in Deciphera Pharmaceuticals Inc by 154.18%. The purchase prices were between $32.73 and $47.95, with an estimated average price of $38.85. The stock is now traded at around $28.330000. The impact to a portfolio due to this purchase was 0.74%. The holding were 1,343,560 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) added to a holding in KalVista Pharmaceuticals Inc by 112.11%. The purchase prices were between $23.12 and $29.91, with an estimated average price of $26.19. The stock is now traded at around $19.380000. The impact to a portfolio due to this purchase was 0.68%. The holding were 2,163,554 shares as of 2021-06-30.

Deerfield Management Company, L.p. (series C) sold out a holding in Boston Scientific Corp. The sale prices were between $38.58 and $44.24, with an estimated average price of $41.97.

Deerfield Management Company, L.p. (series C) sold out a holding in . The sale prices were between $152.35 and $184.3, with an estimated average price of $171.17.

Deerfield Management Company, L.p. (series C) sold out a holding in Biogen Inc. The sale prices were between $259 and $414.71, with an estimated average price of $301.69.

Deerfield Management Company, L.p. (series C) sold out a holding in Deerfield Healthcare Technology Acquisitions Corp. The sale prices were between $12.12 and $15.12, with an estimated average price of $13.12.

Deerfield Management Company, L.p. (series C) sold out a holding in Ortho Clinical Diagnostics Holdings PLC. The sale prices were between $18.15 and $22.31, with an estimated average price of $20.3.

Deerfield Management Company, L.p. (series C) sold out a holding in Hill-Rom Holdings Inc. The sale prices were between $108.25 and $116.66, with an estimated average price of $111.88.